about
NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptorsHydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease.Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest.Melanocortins and the cholinergic anti-inflammatory pathway.Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage.Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect?Modulatory activity of sildenafil on copulatory behaviour of both intact and castrated male rats.Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock.Independent time courses of supraspinal nociceptive activity and spinally mediated behavior during tonic pain.Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat.Effects of ketamine anesthesia on central nociceptive processing in the rat: a 2-deoxyglucose study.Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway.Treatment of cerebral ischemia with melanocortins acting at MC4 receptors induces marked neurogenesis and long-lasting functional recovery.Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway.Effect of sumatriptan in different models of pain in rats.Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models.Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome.Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia.NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling.Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins.Molecular changes induced in rat liver by hemorrhage and effects of melanocortin treatment.Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism.Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils.Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia.Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury*.Melanocortin MC₄ receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia.The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock.Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways.Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat.Influence of eticlopride on cocaine- and DA D2 agonist-induced behavioral effects in rats.Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task.Effect on rat feeding behavior of two selective D2 dopamine agonists.Modulation of the JAK/ERK/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia/reperfusion.Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in ratsCorrigendum to “Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors” [Eur. J. Pharmacol. 477 (2003) 227–234]CNS pattern of metabolic activity during tonic pain: evidence for modulation by β-endorphinEffects of the dopamine D2 agonists lisuride and CQ 32-084 on rat feeding behaviourSuppressive effect of the dopamine D2 receptor agonist B-HT 920 on rat grooming
P50
Q28262350-8993B0B3-272B-44BD-B97A-E1AC210C35C9Q34751757-25DBE40D-F60B-4F85-AD2B-20874E98DC9FQ35208592-B281CD0C-43FF-4BDA-9ED9-C581275938D4Q35466568-FEFE2803-536E-4BBF-85C4-F258906FA5E2Q37827458-3A65646F-A97A-4027-A206-8B3D0B73819EQ42940207-E7025661-CFE3-45D1-AB8D-DB426D15EB6DQ43875060-F4680C73-0E33-4131-9B78-9B44AB468440Q43960645-E28D14C8-0F34-4C7A-9F97-A13865465BD4Q44099989-46EEF4EF-2653-4C7A-BADE-8F0B067DC069Q44342414-D2271B54-3D12-41B2-B6E0-DF35880644BCQ44509540-D0368189-88B4-4D22-B1CE-ED324DDF9808Q44751894-25B05C44-D154-4687-B8A9-9994B862CC7BQ44828716-81D0B5B1-0D58-4A6C-8D3B-343BD99A702AQ44874138-907087A5-2745-4EEF-BBA6-90C6639088BFQ44880939-B17FB7B8-AE04-419D-8EB0-CB0853012EA2Q44974894-D32A413B-891B-47EA-AF9B-A75E8C04A7F7Q45014973-8A99E65C-94DB-433D-8B8D-FC68D394DF40Q45711992-140A72DF-E688-4C7B-9B2A-FDFE7A3EC5B8Q46208545-BA755A7E-53E9-47CE-951B-222FA2499B24Q46547362-3026EF33-EA49-4654-BF37-A3C7140B8351Q47637627-AF29781F-1E37-499B-A62B-B583088B21B8Q48127681-6447AB5C-388F-4E01-9087-F4F7DFC30C1AQ48193055-EB023416-4D7E-4F01-9BFA-BB7C98AB5FE8Q48239592-211B524D-692C-43C0-B93C-50D889DD9789Q48561752-F128C0F0-8C81-4522-A395-DCC8F0CE65AAQ48715071-F0AD02CC-F2CF-4C1A-849D-6C958D7037A5Q48808459-2B4BED85-EA96-4F58-A894-2794DB6D428DQ48880586-CF8171AC-006D-44E7-9E5E-53428A248223Q50074972-805C4F19-41D8-47D2-9335-AF92764D435AQ50717891-6334C646-7095-4BCE-8DB1-485B2ACF6383Q51443626-9EC4A2AA-5915-42BB-8004-084FBE21579DQ51575820-164C30DA-5908-47EA-A53A-A4FE0DCE846DQ52173395-6BD2AE1F-D943-46D0-BFD3-B29C308F06B9Q52213370-AA43C973-E7C6-4BD8-A6A7-FE65EA43FDB5Q54441129-7143F56E-38C2-40CC-B829-8BE159752864Q58819383-ECDD0AB7-073C-4F7F-AB47-38C806FE6EB3Q58855808-99709128-F6D4-42D8-B4C9-2607DB81BBF2Q60683634-FDF1D22B-E362-4AD6-B152-DCB8CC44C4FFQ67516901-5B58CAAD-C3C0-4B73-9D6B-AE226CC9F5E7Q67522847-04B91E7D-2201-4114-AB2A-1A40552918C1
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniela Giuliani
@ast
Daniela Giuliani
@en
Daniela Giuliani
@es
Daniela Giuliani
@nl
Daniela Giuliani
@sl
type
label
Daniela Giuliani
@ast
Daniela Giuliani
@en
Daniela Giuliani
@es
Daniela Giuliani
@nl
Daniela Giuliani
@sl
prefLabel
Daniela Giuliani
@ast
Daniela Giuliani
@en
Daniela Giuliani
@es
Daniela Giuliani
@nl
Daniela Giuliani
@sl
P106
P21
P31
P496
0000-0001-6061-5662